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1. Introduction 
The presence of two distinct species of S-adenosyl- 
methionine (AdoMet) synthetase (ATP:L-methionine 
Sadenosyltransferase, EC 2.5.1.6) has been demon- 
strated in yeast [ 1 ] and rat liver [2-4]. One species of 
rat liver enzyme is strikingly stimulated by dimethyl- 
sulfoxide (Me#O) at low concentration (25 PM) of 
methionine, and the other is stimulated only 1.5-fold 
[2]. Novikoff rat ascites hepatoma cells have been 
reported [3,4] to contain a single form of the enzyme 
corresponding to the less-Me,SO sensitive enzyme in 
elution position on gel filtration. Recently, we have 
partially purified two forms of AdoMet synthetase 
from rat liver and a single form from kidney, repre- 
senting non-hepatic rat tissues [.5]. The liver enzymes, 
termed (Y with low Km for ligands (correspond to 
less-Me$O sensitive enzyme) and 0 with high Km for 
ligands (correspond to Me2SO-stimulated enzyme), have 
app. mol. wt 2.1 X 10’ and 1.6 X lo’, respectively. 
The kidney enzyme with an app. mol. wt 1.9 X 10’ is 
partially inhibited by Me,SO and exhibits low sensitiv- 
ity to SH-blocking reagents. 
Here we have investigated the effect of Me,SO on 
AdoMet synthetase activity from rat liver of pre- 
cancerous states induced by thioacetamide, regenerating 
liver, Morris hepatomas 73 16A and 7794A, and 
Yoshida ascites hepatoma AH 130. Gel-filtration 
chromatography of the cytosol fractions indicates 
that the decrease in Me,SO-stimulation ratio of the 
enzyme activity in thioacetamide-treated rat liver and 
hepatoma is due to the reduction of liver 0 enzyme. 
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2. Materials and methods 
L- [met/zyZ-3H] Methionine (8.7 Ci/mmol) was 
obtained from Radiochemical Centre, England. Male 
Wistar rats (150-200 g) were injected intraperitoneally 
with thioacetamide in 0.15 M NaCl(50 mg/kg body 
wt) at intervals of 24 h. After daily doses of thio- 
acetamide for 9 days, livers were homogenized in 
4 vol. 0.25 M sucrose/3.3 mM MgCl? with a glass- 
Teflon homogenizer. The homogenate was centri- 
fuged at 1000 X g for 10 min and the supernatant 
fluid was centrifuged at 105 000 X g for 1 h to obtain 
the cytosol extract. Nuclei were isolated from the 
1000 X g precipitate as in [6] with 2.2 M sucrose/ 
3.3 mM MgClz. Buffalo strain rats, bearing Morris 
hepatoma 73 16A (survival days, 20-25) and 7794A 
(survival days, 40-l 80), were a kind gift from 
Dr Shigeaki Sato. Yoshida rat ascites hepatoma cells 
(AH 130) were a kind gift from Dr Masami 
Muramatsu. Cells of Morris hepatomas (about 20 days 
after subcutaneous transplantation) and Yoshida 
ascites hepatoma were sonicated in an equal vol. of 
25 mM Tris-HCl @H 7.5)/0.25 M sucrose/3.3 mM 
MgClz on ice for 15 s (X 4) at 20 W, and centrifuged 
at 105 000 X g for 1 h. The cytosol extracts from rat 
liver and hepatoma were dialyzed against Buffer A 
(50 mM Tris-HCl, (pH 7.5)/0.2 mM dithiothreitol/ 
0 .l mM EDTA/lO mM MgC12/20% (v/v) glycerol) 
containing 0.1 M KC1 for 4-6 h. 
AdoMet synthetase activity was determined as in 
[3] with a slight modification, The standard reaction 
mixture (0.1 ml) contained 0.1 M Tris-HCl (pH 9.0), 
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Table 1 
Biochemical changes after treatment of thioacetamide on rat liver 
Treatment RNA Nuclear RNase H 
polymerase I 








0.43 3.30 1.62 510 
2.62 10.10 6.88 8980 
RNA polymerase I was measured by its insensitivity to high levels of o-amanitin 
with liver nuclei as in [ 161. Assays of RNase H were described [ 171. DNA syn- 
thesis was measured by the incorporation of [‘HI thymidine injected into the tail 
vein 1 h before killing. Specific activities of nuclear DNA were measured as in 
[ 181. Each value is the mean of the results obtained from 4-5 rats 
20 mM MgC&, 0.15 M KCl, 5 mM dithiothreitol, 
10 mM ATP, 25 PM L-[methyZ-3H]methionine 
(0.25 PCi) and enzyme fraction. The incubation was 
carried out at 37% for 10 min. One unit of enzyme 
activity was defined as being equivalent to the forma- 
tion of 1 nmol/min of AdoMet in the incubation 
mixture. Protein was determined by the method [7] 
and DNA by the method [8]. 
3. Results and discussion 
A hepatocarcinogen, thioacetamide, increases the 
nucleolar size [9] and stimulates ribosomal RNA 
synthesis in liver ‘[ 1 O-l 21, both of which are charac- 
teristic of many tumors. Moreover, it has been shown 
to produce liver tumors after prolonged treatment 
[ 13,141. The activities of Mg*+-dependent RNase H 
[ 151 as well as RNA polymerase I [ 11 ,121 increase 
several fold within 24 h after a single injection of 
thioacetamide. Alterations in biochemical events after 
administration of thioacetamide for 9 days are shown 
in table 1. A nearly 6-fold increase in the activity of 
RNA polymerase I in nuclei was observed. Increased 
activities in nuclear Mg”+- and Mn*‘-dependent 
RNase H (c .f., [ 151) and in incorporation of [3H] thy- 
midine also occurred. 
The stimulation ratio by Me2S0 of AdoMet syn- 
thetase activity from rat liver of precancerous tates 
induced by repeated daily injections of thioacetamide 
for 9 days decreases to -70% of that of control livers 
(table 2). AdoMet synthetase activities, their sensitiv- 
Table 2 
Effect of Me,SO on AdoMet synthetase activity from rat liver and hepatomas 




Hepatoma AH 130 
Hepatoma 7 316A 
Hepatoma 7794A 
AdoMet synthetase activity Stimulatien 
(units/mg protein) ratio 
(+/-) 













The enzyme activity in the cytosol fraction from each source was assayed in the 
standard reaction mixture with and without 10% (V/V) Me,SO. Each value from 
the liver is the mean of the results obtained from 4-5 rats 
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ity to Me,SO, in regenerating rat liver 24 h after 
operation were not essentially changed compared 
with those from normal ivers. The enzyme activities 
from hepatoma AH 130 and hepatoma 73 16A were 
slightly inhibited by Me,SO, whereas the activity 
from hepatoma 7794A was significantly activated by 
Me,SO (table 2). 
The species of AdoMet synthetase in these cytosol 
fractions were analyzed by Sephadex G-l 50 column 
chromatography. As shown in fig.lA, two peaks of 
AdoMet synthetase activity were observed in normal 
livers, and their apparent molecular weights were 
estimated to be 2 .l -2.3 X 10’ for the first peak (ol) 
and 1.4-1.6 X IO5 for the second peak (0) which was 
3040!5060 30 40 50 60 
Fraction number 
Fig.1. Sephadex G-150 column chromatography of AdoMet 
synthetase from rat liver and hepatomas. The cytosol fraction 
(0.45 ml) from normal rat liver (A, 0.43 unit), Yoshida 
asciteshepatoma AH 130 (B, 1 unit), Morris hepatoma 7316A 
(C, 0.3 unit) and Morris hepatoma 7794A (D, 0.6 unit) was 
chromatographed on a column (0.95 X 110 cm) of Sephadex 
G-150 (superfine, Pharmacia) equilibrated with buffer A con- 
taining 0.1 M KU. Fractions of 0.92 ml were collected and 
20 ~1 aliquots were taken to determine the enzyme activity 
with (0) and without (e) 10% (v/v) Me,SO. The recovery of 
the enzyme activity was .50-70% in each case. The apparent 
molecular weights were estimated as in 1191. Catalase (mol. 
wt 2.4 X 1 OS), lactate dehydrogenase (mol. wt 1.4 X 1 O5 )
and bovine serum albumin (mol. wt 6.7 X 1 04) were used as 
external standard proteins. Void volume (fraction no. 32) 
was determined by employing blue dextran. 
strikingly stimulated by Me*SO. Both a! and /3 enzymes 
absolutely required Mg” and K’ for activity and were 
completely inhibited by p-chloromercuribenzoate 
(c.f. [5]). Compared with normal ivers, with cy and 0 
enzyme activities nearly equal in the standard assay 
conditions without Me$O, the thioacetamide-treated 
livers contained approximately half of the /3 enzyme 
activity relative to a! enzyme activity (not shown). 
The enzymes from hepatoma AH 130 (fig.lB) and 
hepatoma 73 16A (fig.1 C) eluted as a single peak 
between the positions of the (Y and fi enzymes. The 
enzyme activity was slightly inhibited by Me,SO and 
reduced to 70-50% by the addition of pchloro- 
mercuribenzoate (0.5 mM), suggesting that the 
enzymes from these hepatomas are similar to the kid- 
ney enzyme [5] rather than liver a! enzyme. In con- 
trast to hepatomas AH 130 and 73 16A, the enzyme 
from hepatoma 7794A has been shown to have two 
peaks of activity (fig.lD). The first, main peak, 
corresponding in elution position to the enzyme from 
hepatomas AH 130 and 73 16A, was slightly inhibited 
by Me,SO andp-chloromercuribenzoate, whereas the 
second, small peak was remarkably stimulated by 
Me,SO, which corresponds to liver /3 enzyme. 
The results uggest that liver fl enzyme disappears 
during liver carcinogenesis and that in three hepatoma 
strains examined but not in the livers of precancerous 
states induced by thioacetamide the kidney-type 
enzyme appears along with the disappearance of liver 
(Y and 0 enzymes. Preliminary experiments show that 
the liver from rat fetus contains almost all kidney- 
type enzyme. Further investigation of the relation- 
ship between kidney enzyme and the hepatoma- 
specific enzyme is now in progress. 
From these experiments, it is noteworthy that we 
can obtain insight into the stage of liver carcinogenesis 
by assaying AdoMet synthetase with and without 
Me,SO, although the biological action of Me,SO 
remains to be clarified. 
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